BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 16919922)

  • 1. [Apnea of prematurity: risk factors and ambulatory treatment with caffeine citrate].
    Ducrocq S; Biran-Mucignat V; Boelle PY; Lebas F; Baudon JJ; Gold F
    Arch Pediatr; 2006 Oct; 13(10):1299-304. PubMed ID: 16919922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Caffeine citrate utilization for treatment of apnea in French neonatal units].
    Ducrocq S; Biran-Mucignat V; Lebas F; Baudon JJ; Gold F
    Arch Pediatr; 2006 Oct; 13(10):1305-8. PubMed ID: 16872813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caffeine citrate therapy for apnea of prematurity.
    Johnson PJ
    Neonatal Netw; 2011; 30(6):408-12. PubMed ID: 22052121
    [No Abstract]   [Full Text] [Related]  

  • 4. Academic Performance, Motor Function, and Behavior 11 Years After Neonatal Caffeine Citrate Therapy for Apnea of Prematurity: An 11-Year Follow-up of the CAP Randomized Clinical Trial.
    Schmidt B; Roberts RS; Anderson PJ; Asztalos EV; Costantini L; Davis PG; Dewey D; D'Ilario J; Doyle LW; Grunau RE; Moddemann D; Nelson H; Ohlsson A; Solimano A; Tin W;
    JAMA Pediatr; 2017 Jun; 171(6):564-572. PubMed ID: 28437520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caffeine therapy for apnea of prematurity.
    Schmidt B; Roberts RS; Davis P; Doyle LW; Barrington KJ; Ohlsson A; Solimano A; Tin W;
    N Engl J Med; 2006 May; 354(20):2112-21. PubMed ID: 16707748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of caffeine therapy for apnea of prematurity.
    Schmidt B; Roberts RS; Davis P; Doyle LW; Barrington KJ; Ohlsson A; Solimano A; Tin W;
    N Engl J Med; 2007 Nov; 357(19):1893-902. PubMed ID: 17989382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of caffeine for the treatment of apnea of prematurity and bradycardia in a holoprosencephalic child with cleft lip and palate.
    Kumar M; Chawla R; Haloi P; Singh M
    J Clin Anesth; 2013 Dec; 25(8):678-9. PubMed ID: 24100116
    [No Abstract]   [Full Text] [Related]  

  • 8. [Apnea of prematurity: what's new?].
    Moriette G; Lescure S; El Ayoubi M; Lopez E
    Arch Pediatr; 2010 Feb; 17(2):186-90. PubMed ID: 19944573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Real-World Routine Use of Caffeine Citrate in Preterm Infants: A European Postauthorization Safety Study.
    Lista G; Fabbri L; Polackova R; Kiechl-Kohlendorfer U; Papagaroufalis K; Saenz P; Ferrari F; Lasagna G; Carnielli VP;
    Neonatology; 2016; 109(3):221-7. PubMed ID: 26820884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caffeine citrate: when and for how long. A literature review.
    Picone S; Bedetta M; Paolillo P
    J Matern Fetal Neonatal Med; 2012 Oct; 25 Suppl 3():11-4. PubMed ID: 23016611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of caffeine citrate on neural breathing pattern in preterm infants.
    Parikka V; Beck J; Zhai Q; Leppäsalo J; Lehtonen L; Soukka H
    Early Hum Dev; 2015 Oct; 91(10):565-8. PubMed ID: 26217936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of prevention of caffeine citrate on cytokine profile and bronchopulmonary dysplasia in preterm infants with apnea.
    Kou C; Han D; Li Z; Wu W; Liu Z; Zhang Y; Gao Z
    Minerva Pediatr; 2020 Apr; 72(2):95-100. PubMed ID: 30961342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National and international guidelines for neonatal caffeine use: Are they evidenced-based?
    Eichenwald EC
    Semin Fetal Neonatal Med; 2020 Dec; 25(6):101177. PubMed ID: 33214064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caffeine citrate treatment for extremely premature infants with apnea: population pharmacokinetics, absolute bioavailability, and implications for therapeutic drug monitoring.
    Charles BG; Townsend SR; Steer PA; Flenady VJ; Gray PH; Shearman A
    Ther Drug Monit; 2008 Dec; 30(6):709-16. PubMed ID: 19057373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caffeine Citrate Dosing Adjustments to Assure Stable Caffeine Concentrations in Preterm Neonates.
    Koch G; Datta AN; Jost K; Schulzke SM; van den Anker J; Pfister M
    J Pediatr; 2017 Dec; 191():50-56.e1. PubMed ID: 29173321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High versus low-dose caffeine for apnea of prematurity: a randomized controlled trial.
    Mohammed S; Nour I; Shabaan AE; Shouman B; Abdel-Hady H; Nasef N
    Eur J Pediatr; 2015 Jul; 174(7):949-56. PubMed ID: 25644724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When to start and stop caffeine and why respiratory status matters.
    Davis PG
    Semin Fetal Neonatal Med; 2020 Dec; 25(6):101175. PubMed ID: 33144042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caffeine for apnea of prematurity.
    Bancalari E
    N Engl J Med; 2006 May; 354(20):2179-81. PubMed ID: 16707756
    [No Abstract]   [Full Text] [Related]  

  • 19. Caffeine citrate in the NICU.
    Flood E
    Neonatal Netw; 1989 Apr; 7(5):37-9. PubMed ID: 2704353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current options in the management of apnea of prematurity.
    Bhatia J
    Clin Pediatr (Phila); 2000 Jun; 39(6):327-36. PubMed ID: 10879934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.